A double-edged sword
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the Long Term Plan while putting others in jeopardy
Search Results for: Oli Hudson and Paul Midgley
Care in the home
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are increasingly being empowered to manage their conditions at home
Read More
After shock?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of the Tories’ historic win on the NHS and pharma in 2020 and beyond
Read More
2019 – a momentous year for the NHS
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how the Long Term Plan has been driving transformation in the NHS this year
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
